From: Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study
overall | secondary resection | simultaneous resection | ||
---|---|---|---|---|
Extend of first liver resection | ||||
1 segment | 15 (34.9%) | 9 | (30.0%) | 6 (46.2%) |
2 segments | 13 (30.2%) | 8 | (26.7%) | 5 (38.5%) |
mutltiple segments | 1 (2.3%) | 1 | (3.3%) | 0 (0.0%) |
hemihepatectomy | 7 (16.3%) | 6 | (20.0%) | 1 (7.7%) |
extended hemihepatectomy | 3 (7.0%) | 2 | (6.7%) | 1 (7.7%) |
atypical resection | 2 (4.7%) | 2 | (6.7%) | 0 (0.0%) |
unknown | 2 (4.7%) | 2 | (6.7%) | 0 (0.0%) |
Resection Status of first liver resection | ||||
R0 | 30 (69.8%) | 23 | (76.7%) | 7 (53.8%) |
R1 | 8 (18.6%) | 5 | (16.7%) | 3 (23.1%) |
Rx | 5 (11.6%) | 2 | (6.7%) | 3 (23.1%) |
Systemic Therapies after first liver Resectiona | ||||
Mitotane | 21 (48.8%) | 17 | (56.7%) | 4 (30.8%) |
Chemotherapy | 8 (18.6%) | 3 | (10.0%) | 5 (38.5%) |